- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05324813
Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use
April 10, 2022 updated by: Michael Sofis
The overarching goal of this online study is to compare the efficacy of six (weekly) sessions of Domain-Specific Episodic Future Thinking (DS-EFT) relative an active control condition on improving the ability to value future rewards and reducing cannabis use (grams and days of use), tobacco use, and alcohol use among.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Michael J Sofis, PhD
- Phone Number: 14128678991
- Email: msofis@ahpnet.com
Study Locations
-
-
Massachusetts
-
Sudbury, Massachusetts, United States, 01776
- Recruiting
- AHP Corporate Office
-
Contact:
- Michael Sofis
- Phone Number: 412-867-8991
- Email: sofismichael2@gmail.com
-
Principal Investigator:
- Michael J. Sofis, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- at least 18 or older
- reside in the U.S.
- report wanting to reduce cannabis use (4 or higher on scale of 1-10 with higher scores indicating greater desire to reduce use)
- report using cannabis at least 10 days in the last month
- report using cannabis at least 100 days in their lifetime
- Data quality checks passed
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Domain-Specific Episodic Future Thinking
|
Individualized intervention that provides systematic prompts to enable creation and envisioning of positive future events across multiple life domains.
|
Active Comparator: Episodic Recent Thinking Control Condition
|
Individualized intervention that provides systematic prompts to enable creation and envisioning of positive future events across multiple life domains.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of cannabis use grams
Time Frame: 1-week follow-up
|
1-week follow-up
|
Number of cannabis use days
Time Frame: 1-week follow-up
|
1-week follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of tobacco use days
Time Frame: 1-week follow-up
|
1-week follow-up
|
|
Number of alcohol use days
Time Frame: 1-week follow-up
|
1-week follow-up
|
|
Number of tobacco use times
Time Frame: 1-week follow-up
|
1-week follow-up
|
|
Number of alcoholic drinks
Time Frame: 1-week follow-up
|
1-week follow-up
|
|
Rate of delay discounting
Time Frame: 1-week follow-up
|
5-trial adjusting delay discounting task
|
1-week follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael J Sofis, PhD, AHP
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2022
Primary Completion (Anticipated)
July 1, 2022
Study Completion (Anticipated)
July 1, 2022
Study Registration Dates
First Submitted
March 16, 2022
First Submitted That Met QC Criteria
April 10, 2022
First Posted (Actual)
April 12, 2022
Study Record Updates
Last Update Posted (Actual)
April 12, 2022
Last Update Submitted That Met QC Criteria
April 10, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7420
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use
-
University of VirginiaVirginia Foundation for Healthy YouthRecruitingTobacco Use | Electronic Cigarette Use | Tobacco Use CessationUnited States
-
Vanderbilt University Medical CenterCompletedTobacco Use | Tobacco Use Cessation
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
British American Tobacco (Investments) LimitedCompletedTobacco Use | Tobacco SmokingUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco DependenceUnited States
-
RAI Services CompanyRecruitingSmoking | Tobacco Use | Tobacco SmokingUnited States
Clinical Trials on Domain-Specific Episodic Future Thinking
-
University of VermontNot yet recruitingTobacco Smoking
-
Henry Ford Health SystemMichigan State University; University of Kansas; University of Maryland, College...Recruiting
-
Virginia Polytechnic Institute and State UniversityNational Institute of Nursing Research (NINR); Carilion Clinic; University at...CompletedType 2 DiabetesUnited States
-
Henry Ford Health SystemUniversity of Kansas; University of Maryland, College ParkCompletedBehavioral HealthUnited States
-
State University of New York at BuffaloCompletedMedication AdherenceUnited States
-
Henry Ford Health SystemMichigan State University; University of Kansas; University of Maryland, College...CompletedBehavioral HealthUnited States
-
Henry Ford Health SystemUniversity of Kansas; University of Maryland, College ParkEnrolling by invitation
-
Virginia Polytechnic Institute and State UniversityCarilion Clinic; Arizona State UniversityRecruiting
-
Virginia Polytechnic Institute and State UniversityCarilion ClinicCompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Virginia Polytechnic Institute and State UniversityCarilion Clinic; University at BuffaloRecruitingType 2 Diabetes | Overweight and ObesityUnited States